MedPath

Scios, Inc.

Scios, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
1981-01-01
Employees
509
Market Cap
-
Website

Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS

Phase 4
Completed
Conditions
Congestive Heart Failure
Chronic Heart Failure
First Posted Date
2008-04-04
Last Posted Date
2011-05-19
Lead Sponsor
Scios, Inc.
Registration Number
NCT00652652

Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

Phase 2
Completed
Conditions
Coronary Artery Bypass Surgery
Coronary Heart Disease
Coronary Artery Bypass Grafting
Cardiopulmonary Bypass
Ischemic Heart Disease
Congestive Heart Failure
First Posted Date
2008-04-04
Last Posted Date
2011-05-19
Lead Sponsor
Scios, Inc.
Target Recruit Count
305
Registration Number
NCT00653042

An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)

Phase 3
Withdrawn
Conditions
Coronary Artery Bypass Surgery
Coronary Heart Disease
Ischemic Heart Disease
Coronary Artery Bypass Grafting
Cardiopulmonary Bypass
Heart Failure, Congestive
First Posted Date
2007-09-17
Last Posted Date
2016-09-20
Lead Sponsor
Scios, Inc.
Registration Number
NCT00530361

Heart Failure Registry

Completed
Conditions
Heart Failure, Congestive
First Posted Date
2007-09-17
Last Posted Date
2014-01-31
Lead Sponsor
Scios, Inc.
Target Recruit Count
150000
Registration Number
NCT00530426

A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis

Phase 1
Completed
Conditions
Rheumatoid Arthritis
First Posted Date
2007-07-30
Last Posted Date
2011-05-19
Lead Sponsor
Scios, Inc.
Target Recruit Count
16
Registration Number
NCT00508768

A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure

Phase 3
Completed
Conditions
Heart Decompensation
Interventions
Drug: Placebo
First Posted Date
2007-05-21
Last Posted Date
2013-03-08
Lead Sponsor
Scios, Inc.
Target Recruit Count
7141
Registration Number
NCT00475852

Registry for Acute Decompensated Heart Failure Patients

Completed
Conditions
Heart Failure, Congestive
Heart Decompensation
Interventions
Other: Acute Decompensated Heart Failure
First Posted Date
2006-08-21
Last Posted Date
2009-11-01
Lead Sponsor
Scios, Inc.
Target Recruit Count
24118
Registration Number
NCT00366639

Longitudinal Registry for Advanced Heart Failure Patients

Completed
Conditions
Heart Failure, Congestive
Heart Decompensation
Interventions
Other: Any treatment used to treat CHF
First Posted Date
2006-08-15
Last Posted Date
2010-04-28
Lead Sponsor
Scios, Inc.
Target Recruit Count
1466
Registration Number
NCT00364416

Registry for Acute Decompensated Heart Failure Patients Admitted to the ER

Completed
Conditions
Heart Decompensation
Heart Failure, Congestive
Interventions
Other: Acute Decompensated Heart Failure
First Posted Date
2006-08-15
Last Posted Date
2010-04-28
Lead Sponsor
Scios, Inc.
Target Recruit Count
18920
Registration Number
NCT00364325

Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC

Phase 2
Terminated
Conditions
Renal Failure
Cardiac Transplantation
Renal Insufficiency
Congestive Heart Failure
Interventions
Drug: Natrecor (nesiritide)+Standard Care+dobutamine or milrinone
Drug: Placebo+Standard Care+dobutamine or milrinone
First Posted Date
2006-06-20
Last Posted Date
2014-12-08
Lead Sponsor
Scios, Inc.
Target Recruit Count
16
Registration Number
NCT00338455
© Copyright 2025. All Rights Reserved by MedPath